Verve Ventures logo

Verve Ventures

Europe, Zug, Switzerland, Zug

Description

Verve Ventures is a European startup investment platform for private and institutional investors.

Investor Profile

Verve Ventures has made 239 investments, with 20 in the past 12 months and 15% as lead.

Stage Focus

  • Series A (33%)
  • Seed (30%)
  • Series B (17%)
  • Series Unknown (7%)
  • Angel (6%)
  • Series C (5%)
  • Convertible Note (2%)
  • Series D (1%)

Country Focus

  • Switzerland (67%)
  • Germany (8%)
  • France (8%)
  • United Kingdom (6%)
  • United States (2%)
  • Belgium (2%)
  • Austria (2%)
  • Italy (1%)
  • The Netherlands (1%)

Industry Focus

  • Software
  • Health Care
  • Biotechnology
  • Information Technology
  • Artificial Intelligence (Ai)
  • Medical
  • Medical Device
  • Manufacturing
  • Saas
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Verve Ventures frequently co-invest with?

SICTIC
Europe, Zurich, Switzerland, Zürich
Co-Investments: 13
4V
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 8
Swisscanto Private Equity
Europe, Zurich, Switzerland, Zürich
Co-Investments: 13
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 51
Swiss Post Ventures
Europe, Bern, Switzerland, Bern
Co-Investments: 9
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 10
Alpana Ventures
Europe, Geneve, Switzerland, Geneva
Co-Investments: 8
3wVentures
Europe, Ausser-Rhoden, Switzerland, Herisau
Co-Investments: 30
Swisscom Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 17
Business Angels Switzerland (BAS)
Europe, Zurich, Switzerland, Zürich
Co-Investments: 10

Which angels does Verve Ventures often collaborate with?

JR
Europe, Bayern, Germany, Munich
Shared Deals: 2
JC
Europe, Shropshire, United Kingdom, Shrewsbury
Shared Deals: 1
AL
Europe, Zurich, Switzerland, Zurich
Shared Deals: 4
JH
Europe, Bayern, Germany, Ingolstadt
Shared Deals: 2
JZ
North America, California, United States, San Francisco
Shared Deals: 2
MW
Europe, Bayern, Germany, Munich
Shared Deals: 2
MN
Europe, Zurich, Switzerland
Shared Deals: 2
PS
Europe, Zurich, Switzerland, Zürich
Shared Deals: 2
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 2
MP
Europe, Switzerland
Shared Deals: 4

What are some of recent deals done by Verve Ventures?

Zero Point Motion

London, England, United Kingdom

Zero Point Motion develops inertial sensors to enable precision positioning and navigation.

GPSNavigationQuantum Computing
SeedMar 13, 2025
Amount Raised: $5,182,784
Lexroom.ai

Milan, Lombardia, Italy

Lexroom allows lawyers to complete hours of legal research in seconds.

Artificial Intelligence (AI)Information TechnologyLegal
SeedMar 11, 2025
Amount Raised: $2,170,688
Orakl Oncology

Villejuif, Ile-de-France, France

Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.

BiotechnologyMedicalOncologyTherapeutics
SeedDec 3, 2024
Amount Raised: $11,560,451
Metafuels

Zürich, Zurich, Switzerland

Powering the future of aviation with sustainable aviation fuel - affordable air travel without the carbon footprint

Clean EnergyCleanTechGreenTechRenewable Energy
Series ADec 1, 2024
Amount Raised: $9,000,000
tozero

Munich, Bayern, Germany

Recycling lithium-ion batteries.

BatteryRecycling
SeedNov 12, 2024
Amount Raised: $11,678,299
Otoqi

Paris, Ile-de-France, France

Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for automotive professionals.

AutomotiveDeliveryIndustrial
Series BOct 18, 2024
Amount Raised: $10,872,520
Retinai

Bern, Bern, Switzerland

RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare.

Artificial Intelligence (AI)Cloud ComputingHealth CareHealth DiagnosticsInformation TechnologyMachine LearningSoftware
Series BOct 16, 2024
Amount Raised: $7,775,807
Nuclera

Cambridge, Cambridgeshire, United Kingdom

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

BiotechnologyLife SciencePharmaceutical
Series COct 15, 2024
Amount Raised: $75,000,000
Somagenetix

Zürich, Zurich, Switzerland

Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses.

Pharmaceutical
Series AOct 8, 2024
Amount Raised: $11,663,277
Phlair

Ismaning, Bayern, Germany

Phlair develops an electrochemical Direct Air Capture (DAC) that enables CO2 capture from ambient air.

Carbon CaptureChemical EngineeringIndustrial
SeedSep 19, 2024
Amount Raised: $16,181,230